id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-V-0296-0004,FDA,FDA-2004-V-0296,HFA-300 to Hot Wax Unlimited,Other,VRA-Approval for Variance,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:53:30Z,,0,0,0900006480472d00
FDA-2004-V-0296-0001,FDA,FDA-2004-V-0296,HFA-305 to Hot Wax Unlimited,Other,ACK-Acknowledgement Letter,2004-11-22T05:00:00Z,2004,11,,,2008-04-12T00:53:30Z,,0,0,0900006480472cbc
FDA-2004-V-0296-0003,FDA,FDA-2004-V-0296,HFA-305 to Hot Wax Unlimited,Other,ACK-Acknowledgement Letter,2004-11-22T05:00:00Z,2004,11,,,2008-04-12T00:53:30Z,,0,0,0900006480472cff
FDA-2004-V-0296-0002,FDA,FDA-2004-V-0296,HFA-305 to Hot Wax Unlimited,Other,ACK-Acknowledgement Letter,2004-11-22T05:00:00Z,2004,11,,,2008-04-12T00:53:30Z,,0,0,0900006480472cfe